Medication info
Tovastin Tablet 20mg (Atorvastatin Calcium Trihydrate)

Tovastin Tablet 20mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.69mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307570 · Approved 2013.05.31 · Insurance code 693901230

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients taking or about to take atorvastatin should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • hyperbetalipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke, especially in adults with risk factors for coronary heart disease and patients with type 2 diabetes. It also reduces the risk of hospitalization due to vascular interventions, angina, and congestive heart failure. For patients with hyperlipidemia, it effectively lowers total cholesterol and LDL cholesterol levels when combined with a diet, while increasing HDL cholesterol levels. It can be safely used in pediatric patients with familial hypercholesterolemia and helps manage cardiovascular disease risk factors. This medication is effectively used to improve cardiovascular health.

How to take

Adult dose

Patients taking or about to take atorvastatin should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication may pose a risk of muscle problems; therefore, if muscle pain, weakness, or significantly elevated creatine kinase levels occur, use should be discontinued immediately. Patients with active liver disease or severely impaired liver function, those with muscle diseases, pregnant women or women who may become pregnant, children under 10 years old, and those taking specific antiviral treatments should not take this medication. Caution is advised for individuals with a history of alcohol dependence or liver disease, those with impaired kidney function, hypothyroid patients, those with a past of muscle disorders, and elderly patients. This medication is generally well tolerated but can occasionally cause various side effects such as liver function abnormalities, muscle pain, indigestion, headache, allergic reactions, and skin rashes. If symptoms occur, consult a doctor. If muscle pain is accompanied by fatigue or fever, contact a doctor immediately and undergo testing, as discontinuation may be necessary in severe cases. As this medication is metabolized in the liver, patients with poor liver function may require dosage adjustments and should stop use if symptoms of hepatitis (nausea, vomiting, malaise, etc.) appear. Appropriate contraception must be practiced during treatment. Pregnant or breastfeeding women should not use this medication. This medication may interact with several drugs, thus it is crucial to inform your doctor or pharmacist of any other medications being taken, especially when co-administered with specific antibiotics, antifungals, antivirals, or immunosuppressants. In case of overdose, there are no specific antidotes; therefore, treatment should be symptomatic, and liver function and muscle condition should be monitored periodically. Keep out of reach of children, and it is safest to store it in the original container. Elderly patients and those with renal impairment are at higher risk for myopathy; hence careful observation during treatment is necessary.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 162 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric-duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • acute postprandial syndrome
  • bronchitis
  • rhinitis
  • pneumonia
  • shortness of breath
  • asthma
  • sensory abnormalities
  • dizziness
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • dyscoordination
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • anxiety
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • skin dryness
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • increased urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity; therefore, it should be stored in a tightly sealed container. Optimal storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This ensures the drug's effectiveness is preserved.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.